Últimas subidas - Retina Vascular Occlusions
|
Hemi-CRVO - dual trunk veinvista 76 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 105 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 88 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 87 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 75 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 76 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 88 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 85 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 101 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 90 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 92 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 86 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 79 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 106 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 119 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 90 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 127 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 74 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 89 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 98 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 87 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 87 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
Hemi-CRVO - dual trunk veinvista 75 veces81 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomyDiciembre 17, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 125 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 109 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 125 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 114 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 92 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 83 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 121 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 92 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 93 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 95 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 122 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 109 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 93 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvista 92 veces78 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.Octubre 13, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 95 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 78 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 111 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 85 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 79 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 102 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 83 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 93 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 79 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 88 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 118 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 83 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 80 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 93 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 78 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 119 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 93 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 108 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 93 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 88 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevista 103 veces57 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaAgosto 17, 2025
|
|
CRAO and NVI (rubeosis)vista 89 vecesAgosto 13, 2025
|
|
CRAO and NVI (rubeosis)vista 125 vecesAgosto 13, 2025
|
|
BRVO with good visionvista 340 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 355 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 340 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 142 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 128 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 124 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 142 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 167 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 125 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 114 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 131 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 148 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 153 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 122 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 164 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 147 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 143 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 145 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 147 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 124 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
BRVO with good visionvista 156 veces87 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.Julio 27, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 143 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 159 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 140 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 133 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 114 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 150 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 115 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 123 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 189 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 125 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 118 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 131 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 142 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 131 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 158 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 138 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 123 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 130 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvista 144 veces63 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12Julio 22, 2024
|
|
| 1798 archivos en 18 página(s) |
1 |
 |
|
|
|
|
|
|
|
|
|
